Breast cancer drug fulvestrant rejected as a first-line treatment for routine use on the NHS
Source: Breast Cancer Now Breast Cancer Now responds to NICE’s decision to reject fulvestrant as a...
WHAT'S UP IN
Fulvestrant
Pfizer’s Ibrance Gets FDA Approval for Breast Cancer (PFE)
Author: Shobhit Seth / Source: Investopedia U.S. pharmaceutical giant Pfizer Inc. (PFE )...
Abemaciclib-Faslodex Combo Increases Progression-free Survival in Advanced Breast Cancer
Author: Ines Martins / Source: Breast Cancer News Adding the CDK4/6 inhibitor...
